Media & Announcements
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
26th International Scientific Conference on Expert Education Programs.
Polpharma joins the 26th International Scientific Conference on Expert Education Programs (EPE2026), supporting expert-led pharmaceutical education.
Group News
June 1, 2026
Polish RNA Technology Platform
Polpharma opens Poland's only end-to-end RNA medicine development platform in Starogard Gdanski, a PLN 238.7m investment strengthening medicine security.
Science & Innovation
May 20, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Careers
Polpharma Group
May 31, 2023
Most Attractive Employers Poland 2023: Polpharma on the podium of the ranking in the category of Exact Sciences
Polpharma takes a podium spot in the Exact Sciences category of the Most Attractive Employers Poland 2023 survey of over 12,000 students.
Group News
Polpharma Group
April 29, 2023
Two The Nicholas Hall CHC Marketing Awards 2023 for Polpharma products!
Polpharma products receive two Nicholas Hall CHC Marketing Awards 2023, among the consumer-health industry's most significant honours.
Science & Innovation
ZF Polpharma
March 30, 2023
Polpharma is a leader among Polish companies in terms of the number of European patent applications
EPO's 2022 report places Polpharma fifth in Poland with 11 European patent applications, the only company listed alongside universities and institutes.
Corporate Social Responsibility
ZF Polpharma
March 22, 2023
Polpharma is a Super Ethical Company
Polpharma receives the Super Ethical Company title for the third time, recognising comprehensive work on an ethics- and values-based organisational culture.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY